Davidson Kempner Capital Management LP Sage Therapeutics, Inc. Transaction History

Davidson Kempner Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $20.3 Million - $29.3 Million	369,961 Added 93.89%	763,998 $43.3 Million
Q1 2021 May 17, 2021	BUY	$70.65 - $96.76 $6.08 Million - $8.32 Million	86,037 Added 27.93%	394,037 $29.5 Million
Q4 2020 Feb 16, 2021	BUY	$58.41 - $89.06 $12.9 Million - $19.6 Million	220,600 Added 252.4%	308,000 $26.6 Million
Q3 2020 Nov 16, 2020	BUY	$41.13 - $62.45 $3.59 Million - $5.46 Million	87,400 New	87,400 $5.34 Million

222

52.7M

207K

191K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $641M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Davidson Kempner Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Davidson Kempner Capital Management LP with notifications on news.